{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T21:37:03Z","timestamp":1792445823910,"version":"4.5.0"},"reference-count":28,"publisher":"American Society of Hematology","issue":"23","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,6,5]]},"abstract":"<jats:sec>\n                  <jats:title>Abstract<\/jats:title>\n                  <jats:p>We used single-cell genomics to characterize a patient with T-cell acute lymphoblastic leukemia treated in the Children\u2019s Oncology Group AALL0434 trial with poor clinical outcome despite favorable genomic features, identifying a STAT1-mediated interferon-related transcriptional signature and inflammatory microenvironment associated with sensitivity to small-molecule JAK inhibition.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1182\/blood.2025028566","type":"journal-article","created":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T19:21:12Z","timestamp":1742325672000},"page":"2793-2798","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":4,"title":["STAT1-mediated interferon signatures are associated with preclinical JAK inhibitor sensitivity in T-ALL"],"prefix":"10.1182","volume":"145","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9061-3593","authenticated-orcid":false,"given":"Jason","family":"Xu","sequence":"first","affiliation":[{"name":"1Graduate Group in Genomics and Computational Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA"},{"name":"2Medical Scientist Training Program, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3057-3550","authenticated-orcid":false,"given":"Jonathan H.","family":"Sussman","sequence":"additional","affiliation":[{"name":"1Graduate Group in Genomics and Computational Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA"},{"name":"2Medical Scientist Training Program, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-1620-3493","authenticated-orcid":false,"given":"Austin","family":"Yang","sequence":"additional","affiliation":[{"name":"3Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Yoshimura","sequence":"additional","affiliation":[{"name":"4Department of Pharmacy and Pharmaceutical Sciences, St. Jude Children\u2019s Research Hospital, Memphis, TN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianzhong","family":"Hu","sequence":"additional","affiliation":[{"name":"4Department of Pharmacy and Pharmaceutical Sciences, St. Jude Children\u2019s Research Hospital, Memphis, TN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changya","family":"Chen","sequence":"additional","affiliation":[{"name":"3Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiffaney","family":"Vincent","sequence":"additional","affiliation":[{"name":"3Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shovik","family":"Bandyopadhyay","sequence":"additional","affiliation":[{"name":"2Medical Scientist Training Program, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA"},{"name":"5Graduate Group in Cell and Molecular Biology, University of Pennsylvania, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9501-2263","authenticated-orcid":false,"given":"Elizabeth Y.","family":"Li","sequence":"additional","affiliation":[{"name":"3Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA"},{"name":"6Department of Pediatrics, Yale School of Medicine, New Haven, CT"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tristan","family":"Lim","sequence":"additional","affiliation":[{"name":"7Department of Internal Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0786-8035","authenticated-orcid":false,"given":"Omar","family":"Elghawy","sequence":"additional","affiliation":[{"name":"7Department of Internal Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2333-7530","authenticated-orcid":false,"given":"Adam","family":"Barsouk","sequence":"additional","affiliation":[{"name":"7Department of Internal Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damjan","family":"Karanfilovski","sequence":"additional","affiliation":[{"name":"7Department of Internal Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shira L.","family":"Wald","sequence":"additional","affiliation":[{"name":"7Department of Internal Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory M.","family":"Chen","sequence":"additional","affiliation":[{"name":"1Graduate Group in Genomics and Computational Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA"},{"name":"8Department of Pathology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6197-7091","authenticated-orcid":false,"given":"David","family":"Wu","sequence":"additional","affiliation":[{"name":"3Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3022-8052","authenticated-orcid":false,"given":"Haley","family":"Newman","sequence":"additional","affiliation":[{"name":"3Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Li","sequence":"additional","affiliation":[{"name":"3Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusha","family":"Sun","sequence":"additional","affiliation":[{"name":"3Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5239-1574","authenticated-orcid":false,"given":"Chia-Hui","family":"Chen","sequence":"additional","affiliation":[{"name":"3Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0691-356X","authenticated-orcid":false,"given":"Kathrin","family":"Bernt","sequence":"additional","affiliation":[{"name":"3Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA"},{"name":"9Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7414-3969","authenticated-orcid":false,"given":"Brent L.","family":"Wood","sequence":"additional","affiliation":[{"name":"10Department of Pathology and Laboratory Medicine, Children's Hospital Los Angeles, Los Angeles, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart S.","family":"Winter","sequence":"additional","affiliation":[{"name":"11Division of Hematology Oncology, Children's Minnesota, Eagan, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly P.","family":"Dunsmore","sequence":"additional","affiliation":[{"name":"12Division of Oncology, University of Virginia Health Sciences Center, Charlottesville, VA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Raetz","sequence":"additional","affiliation":[{"name":"13Department of Pediatrics, New York University Langone Health, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1099-3478","authenticated-orcid":false,"given":"Meenakshi","family":"Devidas","sequence":"additional","affiliation":[{"name":"14Department of Biostatistics, St. Jude Children\u2019s Research Hospital, Memphis, TN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9167-2114","authenticated-orcid":false,"given":"Stanley","family":"Pounds","sequence":"additional","affiliation":[{"name":"14Department of Biostatistics, St. Jude Children\u2019s Research Hospital, Memphis, TN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4099-4700","authenticated-orcid":false,"given":"Mignon","family":"Loh","sequence":"additional","affiliation":[{"name":"15Ben Towne Center for Childhood Cancer Research, Seattle Children\u2019s Hospital, Fred Hutch Cancer Center, University of Washington, Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5492-3957","authenticated-orcid":false,"given":"Stephen P.","family":"Hunger","sequence":"additional","affiliation":[{"name":"3Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA"},{"name":"9Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark Y.","family":"Chiang","sequence":"additional","affiliation":[{"name":"16Division of Hematology and Oncology, University of Michigan, Ann Arbor, MI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Diorio","sequence":"additional","affiliation":[{"name":"3Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5558-7967","authenticated-orcid":false,"given":"Danika","family":"Di Giacomo","sequence":"additional","affiliation":[{"name":"17Department of Pathology, St. Jude Children\u2019s Research Hospital, Memphis, TN"},{"name":"18Department of Chemistry, Biology and Biotechnology, University of Perugia, Perugia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6128-9985","authenticated-orcid":false,"given":"Petri","family":"P\u00f6l\u00f6nen","sequence":"additional","affiliation":[{"name":"17Department of Pathology, St. Jude Children\u2019s Research Hospital, Memphis, TN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1871-1850","authenticated-orcid":false,"given":"Charles G.","family":"Mullighan","sequence":"additional","affiliation":[{"name":"17Department of Pathology, St. Jude Children\u2019s Research Hospital, Memphis, TN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun J.","family":"Yang","sequence":"additional","affiliation":[{"name":"4Department of Pharmacy and Pharmaceutical Sciences, St. Jude Children\u2019s Research Hospital, Memphis, TN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9104-5567","authenticated-orcid":false,"given":"Kai","family":"Tan","sequence":"additional","affiliation":[{"name":"3Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA"},{"name":"9Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA"},{"name":"19Center for Single-Cell Biology, Children\u2019s Hospital of Philadelphia, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7373-8987","authenticated-orcid":false,"given":"David T.","family":"Teachey","sequence":"additional","affiliation":[{"name":"3Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA"},{"name":"9Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"21","key":"2025060511214854600_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/blood.V124.21.1.1","article-title":"T-lymphoblastic leukemia (T-ALL) shows excellent outcome, lack of significance of the early thymic precursor (ETP) immunophenotype, and validation of the prognostic value of end-induction minimal residual disease (MRD) in Children\u2019s Oncology Group (COG) Study AALL0434 [abstract]","volume":"124","author":"Wood","year":"2014","journal-title":"Blood"},{"issue":"16","key":"2025060511214854600_bib2","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1056\/NEJMra1400972","article-title":"Acute lymphoblastic leukemia in children.","volume":"373","author":"Hunger","year":"2015","journal-title":"N Engl J Med"},{"issue":"11","key":"2025060511214854600_bib3","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1182\/blood-2014-06-580480","article-title":"Efficacy of JAK\/STAT pathway inhibition in murine xenograft models of early T-cell precursor (ETP) acute lymphoblastic leukemia","volume":"125","author":"Maude","year":"2015","journal-title":"Blood"},{"issue":"12","key":"2025060511214854600_bib4","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1038\/leu.2017.136","article-title":"JAK\/STAT pathway inhibition overcomes IL7-induced glucocorticoid resistance in a subset of human T-cell acute lymphoblastic leukemias","volume":"31","author":"Delgado-Martin","year":"2017","journal-title":"Leukemia"},{"issue":"suppl 1","key":"2025060511214854600_bib5","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1182\/blood-2021-153291","article-title":"Treatment Resistance in ETP-ALL is associated with progenitor-like arrest state [abstract]","volume":"138","author":"Chen","year":"2021","journal-title":"Blood"},{"issue":"47","key":"2025060511214854600_bib6","doi-asserted-by":"crossref","first-page":"18490","DOI":"10.1073\/pnas.0809242105","article-title":"An interferon-related gene signature for DNA damage resistance is a predictive marker for chemotherapy and radiation for breast cancer","volume":"105","author":"Weichselbaum","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"D1","key":"2025060511214854600_bib7","doi-asserted-by":"crossref","first-page":"D380","DOI":"10.1093\/nar\/gkx1013","article-title":"TRRUST v2: an expanded reference database of human and mouse transcriptional regulatory interactions","volume":"46","author":"Han","year":"2018","journal-title":"Nucleic Acids Res"},{"issue":"8027","key":"2025060511214854600_bib8","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1038\/s41586-024-07807-0","article-title":"The genomic basis of childhood T-lineage acute lymphoblastic leukaemia","volume":"632","author":"P\u00f6l\u00f6nen","year":"2024","journal-title":"Nature"},{"issue":"11","key":"2025060511214854600_bib9","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/s41577-020-0306-5","article-title":"A guide to cancer immunotherapy: from T cell basic science to clinical practice","volume":"20","author":"Waldman","year":"2020","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"2025060511214854600_bib10","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1158\/1535-7163.MCT-17-0667","article-title":"JAK2 inhibitor SAR302503 abrogates PD-L1 expression and targets therapy-resistant non-small cell lung cancers","volume":"17","author":"Pitroda","year":"2018","journal-title":"Mol Cancer Ther"},{"issue":"6","key":"2025060511214854600_bib11","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1016\/j.cell.2016.11.022","article-title":"Tumor interferon signaling regulates a multigenic resistance program to immune checkpoint blockade","volume":"167","author":"Benci","year":"2016","journal-title":"Cell"},{"issue":"1","key":"2025060511214854600_bib12","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/jha2.143","article-title":"Ruxolitinib is effective in the treatment of a patient with refractory T-ALL","volume":"2","author":"Jaramillo","year":"2021","journal-title":"EJHaem"},{"key":"2025060511214854600_bib13","doi-asserted-by":"crossref","first-page":"106925","DOI":"10.1016\/j.leukres.2022.106925","article-title":"Efficacy of ruxolitinib in acute lymphoblastic leukemia: a systematic review","volume":"121","author":"Ko\u0142odrubiec","year":"2022","journal-title":"Leuk Res"},{"issue":"8","key":"2025060511214854600_bib14","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1517\/13543784.2011.589383","article-title":"A potential role of ruxolitinib in leukemia","volume":"20","author":"Naqvi","year":"2011","journal-title":"Expert Opin Investig Drugs"},{"issue":"6","key":"2025060511214854600_bib15","doi-asserted-by":"crossref","first-page":"e310","DOI":"10.1097\/HS9.0000000000000310","article-title":"Ruxolitinib synergizes with dexamethasone for the treatment of T-cell acute lymphoblastic leukemia","volume":"3","author":"Verbeke","year":"2019","journal-title":"HemaSphere"},{"issue":"32","key":"2025060511214854600_bib16","doi-asserted-by":"crossref","first-page":"22605","DOI":"10.18632\/oncotarget.25194","article-title":"Inhibiting Janus Kinase 1 and BCL-2 to treat T cell acute lymphoblastic leukemia with IL7-R\u03b1 mutations","volume":"9","author":"Senkevitch","year":"2018","journal-title":"Oncotarget"},{"issue":"15","key":"2025060511214854600_bib17","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.1038\/s41388-018-0624-2","article-title":"Type I interferon\/IRF7 axis instigates chemotherapy-induced immunological dormancy in breast cancer","volume":"38","author":"Lan","year":"2019","journal-title":"Oncogene"},{"issue":"4","key":"2025060511214854600_bib18","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1101\/gad.289769.116","article-title":"A prosurvival DNA damage-induced cytoplasmic interferon response is mediated by end resection factors and is limited by Trex1","volume":"31","author":"Erdal","year":"2017","journal-title":"Genes Dev"},{"issue":"11","key":"2025060511214854600_bib19","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/nm.3708","article-title":"Cancer cell\u2013autonomous contribution of type I interferon signaling to the efficacy of chemotherapy","volume":"20","author":"Sistigu","year":"2014","journal-title":"Nat Med"},{"issue":"1","key":"2025060511214854600_bib20","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ccell.2015.06.006","article-title":"CHZ868, a type II JAK2 inhibitor, reverses type I JAK inhibitor persistence and demonstrates efficacy in myeloproliferative neoplasms","volume":"28","author":"Meyer","year":"2015","journal-title":"Cancer Cell"},{"issue":"1","key":"2025060511214854600_bib21","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/s41591-022-02112-7","article-title":"Pharmacotypes across the genomic landscape of pediatric acute lymphoblastic leukemia and impact on treatment response","volume":"29","author":"Lee","year":"2023","journal-title":"Nat Med"},{"issue":"1","key":"2025060511214854600_bib22","doi-asserted-by":"crossref","first-page":"e29653","DOI":"10.1371\/journal.pone.0029653","article-title":"Expression signature of IFN\/STAT1 signaling genes predicts poor survival outcome in glioblastoma multiforme in a subtype-specific manner","volume":"7","author":"Duarte","year":"2012","journal-title":"PLOS ONE"},{"issue":"6","key":"2025060511214854600_bib23","doi-asserted-by":"crossref","first-page":"e5821","DOI":"10.1371\/journal.pone.0005821","article-title":"STAT1 pathway mediates amplification of metastatic potential and resistance to therapy","volume":"4","author":"Khodarev","year":"2009","journal-title":"PLoS ONE"},{"issue":"8","key":"2025060511214854600_bib24","doi-asserted-by":"crossref","first-page":"e978","DOI":"10.1002\/ctm2.978","article-title":"The driver role of JAK-STAT signalling in cancer stemness capabilities leading to new therapeutic strategies for therapy- and castration-resistant prostate cancer","volume":"12","author":"Lo","year":"2022","journal-title":"Clin Transl Med"},{"issue":"779","key":"2025060511214854600_bib25","doi-asserted-by":"crossref","first-page":"eadr2012","DOI":"10.1126\/scitranslmed.adr2012","article-title":"An inflammatory state defines a high-risk T-lineage acute lymphoblastic leukemia subgroup","volume":"17","author":"Gower","year":"2025","journal-title":"Sci Transl Med"},{"issue":"2","key":"2025060511214854600_bib26","first-page":"158","article-title":"IL-7 receptor expression is frequent in T-cell acute lymphoblastic leukemia and predicts sensitivity to JAK inhibition","volume":"142","author":"Courtois","year":"2023","journal-title":"Blood"},{"issue":"11","key":"2025060511214854600_bib27","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1182\/blood.2024026482","article-title":"Targeting senescent stemlike subpopulations in Philadelphia chromosome-like acute lymphoblastic leukemia","volume":"145","author":"Ding","year":"2025","journal-title":"Blood"},{"key":"2025060511214854600_bib28","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/s43018-024-00863-5","article-title":"A multiomic atlas identifies a treatment-resistant, bone marrow progenitor-like cell population in T cell acute lymphoblastic leukemia","volume":"6","author":"Xu","year":"2025","journal-title":"Nat Cancer"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/145\/23\/2793\/2378106\/blood_bld-2025-028566-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/145\/23\/2793\/2378106\/blood_bld-2025-028566-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T15:21:58Z","timestamp":1749136918000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/145\/23\/2793\/536117\/STAT1-mediated-interferon-signatures-are"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,5]]},"references-count":28,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2025,6,5]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2025028566","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,6,5]]},"published":{"date-parts":[[2025,6,5]]}}}